Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Vasc Interv Radiol ; 31(4): 667-673, 2020 04.
Article in English | MEDLINE | ID: mdl-32113797

ABSTRACT

PURPOSE: To determine predictors of outcomes for patients who undergo computed tomography (CT)-guided percutaneous abdominal or pelvic drainage catheter placement and to identify which patients benefit from fluoroscopic drainage catheter interrogation (abscessogram). MATERIALS AND METHODS: A retrospective review of 383 patients (mean, 52 years old; range 8-89 years old; 158 males: 225 females) who underwent 442 CT-guided procedures and 489 catheter placements for fluid collections in the abdomen or pelvis from January 1, 2015, to December 31, 2016 was performed. Variables including underlying disease, fluid location, number of collections drained, number of catheter exchanges and follow-up abscessograms performed, catheter size, and fistula detection were analyzed to determine factors associated with fistula formation and increased catheter dwell time. RESULTS: A single abscessogram followed by catheter removal was performed for 217 catheters (44%). An increased number of abscessograms was significantly associated with drainage catheter size (P < .001) and presence of a fistula (P < .001). Fistulae were detected in 95 cases (19%) and were significantly associated with an increased number of drain exchanges (P < .001) and an underlying diagnosis of Crohn's disease (P = .02). Based on these data, a clinical algorithm for drain management is presented. CONCLUSIONS: Abscessograms performed after CT-guided percutaneous drainage catheter placement are useful to detect catheter malposition, occluded catheters, and fistulae but are not necessary for all patients. If performed selectively, particularly in patients with an underlying diagnosis of Crohn's disease or those at high risk for developing fistulae, unnecessary examinations can be avoided, reducing cost, extra hospital visits, and radiation dose.


Subject(s)
Abdominal Abscess/therapy , Drainage , Radiography, Interventional , Tomography, X-Ray Computed , Abdominal Abscess/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Catheters , Child , Drainage/adverse effects , Drainage/instrumentation , Equipment Design , Equipment Failure , Female , Fistula/etiology , Humans , Male , Middle Aged , Pelvis , Radiography, Interventional/adverse effects , Retrospective Studies , Risk Factors , Tomography, X-Ray Computed/adverse effects , Treatment Outcome , Young Adult
2.
J Magn Reson Imaging ; 50(5): 1367-1376, 2019 11.
Article in English | MEDLINE | ID: mdl-30883988

ABSTRACT

Appendicitis is the most common cause of acute abdominal pain resulting in surgery. While historically ultrasound (US) and computed tomography (CT) have been used to evaluate for appendicitis and its related complications, magnetic resonance imaging (MRI) has become a highly accurate and increasingly utilized modality in the last two decades, particularly in the pediatric and pregnant patient populations in whom ionizing radiation is used reluctantly. This article discusses the advantages and disadvantages of MRI as a modality to evaluate for acute appendicitis, summarizes studies of the diagnostic performance relative to CT and US, provides a standard MR protocol, and describes MRI findings typical of acute appendicitis, common complications, and other differential diagnoses. Level of Evidence: 2 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019;50:1367-1376.


Subject(s)
Appendicitis/diagnostic imaging , Diagnosis, Differential , Magnetic Resonance Imaging , Abscess/diagnostic imaging , Acute Disease , Cholecystitis/diagnostic imaging , Female , Gadolinium , Humans , Male , Ovary/pathology , Pelvic Inflammatory Disease/diagnostic imaging , Peritonitis/diagnostic imaging , Pregnancy , Pregnancy Complications/diagnostic imaging , Pyelonephritis/diagnostic imaging , Tomography, X-Ray Computed , Torsion Abnormality/diagnostic imaging , Ultrasonography , Urolithiasis/diagnostic imaging
3.
Bioorg Med Chem Lett ; 14(24): 6113-6, 2004 Dec 20.
Article in English | MEDLINE | ID: mdl-15546740

ABSTRACT

To understand the species selectivity in a series of alpha-methyl-alpha-phenoxy carboxylic acid PPARalpha/gamma dual agonists (1-11), structure-based molecular modeling was carried out in the ligand binding pockets of both human and mouse PPARalpha. This study suggested that interaction of both 4-phenoxy and phenyloxazole substituents of these ligands with F272 and M279 in mouse PPARalpha leads to the species-specific divergence in ligand binding. Insights obtained in the molecular modeling studies of these key interactions resulted in the ability to convert a human-selective PPARalpha agonist to a human and mouse dual agonist within the same platform.


Subject(s)
Cinnamates/chemical synthesis , Models, Molecular , PPAR alpha/agonists , Animals , Cinnamates/chemistry , Cinnamates/pharmacology , Drug Design , Humans , Ligands , Mice , Molecular Structure , Species Specificity , Structure-Activity Relationship
4.
J Med Chem ; 47(10): 2422-5, 2004 May 06.
Article in English | MEDLINE | ID: mdl-15115385

ABSTRACT

The design and synthesis of the dual peroxisome proliferator activated receptor (PPAR) alpha/gamma agonist (S)-2-methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropionic acid (2) for the treatment of type 2 diabetes and associated dyslipidemia are described. 2 possesses a potent dual hPPAR alpha/gamma agonist profile (IC(50) = 28 and 10 nM; EC(50) = 9 and 4 nM, respectively, for hPPARalpha and hPPARgamma). In preclinical models, 2 substantially improves insulin sensitivity and potently reverses diabetic hyperglycemia while significantly improving overall lipid homeostasis.


Subject(s)
Hypoglycemic Agents/chemical synthesis , Hypolipidemic Agents/chemical synthesis , Phenylpropionates/chemical synthesis , Receptors, Cytoplasmic and Nuclear/agonists , Thiophenes/chemical synthesis , Transcription Factors/agonists , Animals , Binding, Competitive , Cell Line , Diabetes Mellitus, Type 2/drug therapy , Female , Humans , Hyperlipidemias/drug therapy , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Phenylpropionates/chemistry , Phenylpropionates/pharmacology , Radioligand Assay , Rats , Rats, Zucker , Stereoisomerism , Structure-Activity Relationship , Thiophenes/chemistry , Thiophenes/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...